Navigation Links
Kendle Announces Postponement of 2011 Annual Meeting

CINCINNATI, May 6, 2011 /PRNewswire/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the Company is postponing its Annual Meeting of Shareholders due to its merger agreement with INC Research, LLC.  The annual meeting had been scheduled for May 19, 2011, in Cincinnati, Ohio.  Kendle announced May 4, 2011, that it has signed a merger agreement with INC Research.  The merger transaction requires the approval of Kendle's shareholders.

The annual meeting was postponed to provide shareholders adequate information and time to review the proposed merger.  At a later date, Kendle's Board of Directors will establish a new record date and meeting date for the annual meeting and the Company will send a revised annual meeting notice and proxy statement to shareholders.

Kendle believes it is appropriate to avoid the unnecessary cost of holding both an annual meeting to address the five proposals included in the Proxy Statement sent April 15, 2011, and another special shareholders' meeting to approve the merger.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry.  Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing products to market for the benefit of patients worldwide.  As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.  For more information, please visit

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the proposed transaction between Kendle and INC Research and the expected timing and completion of the transaction. Words such as "anticipate," "believe," "plan," "estimate," "expect," "intend," "will," "should," "may," and other similar expressions are intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of Kendle's management and involve a number of significant risks and uncertainties, many of which are difficult to predict and are generally beyond the control of Kendle and INC Research. Actual results may differ materially from the results anticipated in these forward-looking statements. There can be no assurance as to the timing of the closing of the transaction, or whether the transaction will close at all. The following factors, among others, could cause or contribute to such material differences: the ability to obtain the approval of the transaction by Kendle's shareholders; the ability to obtain required regulatory approvals of the transaction or to satisfy other conditions to the transaction on the terms and expected timeframe or at all; transaction costs; economic conditions; a material adverse change in the business, assets, financial condition or results of operations of Kendle; and the effects of disruption from the transaction making it more difficult to maintain relationships with employees, customers or other business partners. Additional factors that could cause Kendle's results to differ materially from those described in the forward-looking statements can be found in the periodic reports filed with the Securities and Exchange Commission and in the proxy statement Kendle intends to file with the Securities and Exchange Commission and mail to its shareholders with respect to the proposed transaction, which are or will be available at the Securities and Exchange Commission's website ( at no charge. Kendle assumes no responsibility to update any forward-looking statements as a result of new information or future developments except as expressly required by law.

Additional Information

This communication is being made in respect of the proposed merger transaction involving Kendle and INC Research. In connection with the proposed transaction, Kendle will file with the Securities and Exchange Commission a proxy statement and will mail the proxy statement to its shareholders. Shareholders are encouraged to read the proxy statement regarding the proposed transaction in its entirety when it becomes available, and before making any voting decision, as it will contain important information about the transaction. Shareholders will be able to obtain a free copy of the proxy statement (when available), as well as other filings made by Kendle regarding the Company, INC Research and the proposed transaction, without charge, at the Securities and Exchange Commission's website ( These materials also can be obtained, when available, without charge, by directing a request to Kendle at

Participants in the Solicitation

Kendle, INC Research and their respective executive officers, directors and other persons may be deemed to be participants in the solicitation of proxies from Kendle's shareholders with respect to the special meeting of shareholders that will be held to consider the proposed transaction. Information regarding the officers and directors of Kendle is included in its Annual Report on Form 10-K for the year ended Dec. 31, 2010, and the Company's notice of Annual Meeting of Shareholders and Proxy Statement, which were filed with the Securities and Exchange Commission on March 16, 2011, and April 15, 2011, respectively. Other information regarding the participants in the solicitation and a description of their direct and indirect interests, by security holdings or otherwise, which may be different than those of Kendle's shareholders generally, will be contained in the proxy statement (when filed) and other relevant materials to be filed with the Securities and Exchange Commission in connection with the proposed transaction.

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. INC Research to Acquire Kendle International for $15.25 per Share in Cash
2. Kendle Chairman and CEO Receives Lifetime Achievement Award at Cincinnati USA Innovation Awards
3. Kendle Executives to Share Insights at 20th Annual Partnerships in Clinical Trials Conference
4. Kendle Announces Fourth Quarter and Full-Year 2010 Results
5. Kendle Appoints Martha Feller, PhD, Vice President and Global Head, Study Start-up
6. Kendle Announces CEO Succession Plan, Promotes Stephen Cutler, PhD, to President and CEO
7. Kendle to Present at Lazard Capital Markets 7th Annual Healthcare Conference
8. Kendle Announces Details Regarding Third Quarter 2010 Earnings Conference Call and Webcast
9. Kendle Appoints Mark J. Roseman, D.Sc., Senior Vice President and Chief Marketing Officer
10. Kendle Announces Details Regarding Second Quarter 2010 Earnings Conference Call and Webcast
11. Kendle to Present at 2010 Wells Fargo Securities Healthcare Conference
Post Your Comments:
(Date:11/26/2015)... India , November 26, 2015 ... --> adds ... Report" and "Investigation Report on China ... and 2021 forecasts data and information ... . ...
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... European Cell Surface Marker Testing Market: ...  report to their offering.  --> ... addition of the  "2016 Future Horizons ...
(Date:11/25/2015)... , Nov. 25, 2015  The American Academy ... Gynecologists (ACOG), and the March of Dimes cheered ... Protecting Our Infants Act of 2015 (S.799), ... of newborns born exposed to drugs, such as ... bill,s introduction, all three organizations have worked together ...
Breaking Medicine Technology:
(Date:11/30/2015)... INDIANAPOLIS, IN (PRWEB) , ... November 30, 2015 ... ... provider of carrier-grade software solutions and services which empower organizations through communication analytics, ... users, helping them effectively monitor and manage their service quality. , Proteus® ...
(Date:11/29/2015)... ... November 29, 2015 , ... NewsWatch featured X-wing as part of its ... Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted the review and ... future. , It’s the future because flying cars are about to become a reality. ...
(Date:11/29/2015)... ... November 29, 2015 , ... Effective immediately, every single ... addition starting on Black Friday Target is offering a “Buy One Scrub Set, Get ... a rare opportunity to purchase IguanaMed at a discounted price. , IguanaMed’s ...
(Date:11/28/2015)... ... ... Beginning November 30th at 6:00 a.m. EST until 11:59 p.m. EST, customers ... up to 20% off orders $80 or more to free gifts with purchases, there will ... As a competitive e-commerce website for skin care and cosmetic needs, customers will save on ...
(Date:11/27/2015)... CO (PRWEB) , ... November 27, 2015 , ... According ... cities are not changing the way that they are handling security in light of ... police and security presence in an attempt to stop an attack from reaching U.S. ...
Breaking Medicine News(10 mins):